Wishing You a Lifetime of Happiness
Our gene therapies provide patients with preventive healthcare
#1105 Yurakucho Itocia Office Tower 11F, 2-7-1 Yurakucho, Chiyoda-ku, Tokyo 100-0006
1 min. walk from JR / Subway "Yurakucho Station" 2 min. walk from subway "Ginza Station"
About our Director
Director of HIC Clinic
Dr. Tetsuyuki Hirahata, M.D., Ph.D.
Upon returning to Japan, he established Hirahata Clinic and also founded UDX Hirahata Clinic and its affiliated research institute in Akihabara, Tokyo, in 2008. Both medical facilities were created to provide specialized healthcare services in the fields of genetic testing and treatment, and Dr. Hirahata continues to advance these same lines of research at HIC Clinic and its associated research laboratory.
Former President of Soyukai Medical Corporation
Former Director of the Institute for Genetic Diagnosis and Treatment
Board-Certified Physician, American Academy of Anti-Aging Medicine (A4M)
Professional Affiliations: Japanese Society of Internal Medicine, Japan Pancreas Society, Japanese Society for Gene Diagnosis and Therapy, Japan Society of Human Genetics, and American Society of Human Genetics.
About our Doctor
Dr. Shinji Kashiki, M.D., Ph.D.
Board Certified Member of the Japanese Society of Internal Medicine, Board Certified Member of the Japanese Society of Cardiovascular Medicine, Occupational Health Physician
1986 Graduated from Teikyo University School of Medicine
1987 Tokyo Medical University, the Second Department of Internal Medicine
1988 Toda Central General Hospital, Department of Cardiovascular Medicine
2015 Totsuka Kyoritsu Daiichi Hospital, Director of Dialysis Center
2018 Himonya Hospital, Chief, Department of Internal Medicine
2021 Ginza Sukiyabashi Clinic, Director
2022 HIC Clinic, Permanent Physician
Our Research Facility
A medical clinic with an affiliated genetic research facility
We also freeze patients’ donor cells such as natural killer (NK) cells and store them in liquid nitrogen at -196°C—making it easy to reproduce cell-based therapies for cancer patients in need.